How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper
27 Feb, 2022
Authors: Neumann E, Schreeck F, Herberg J, Jacqz Aigrain E, Maitland-van der Zee AH, Pérez-Martínez A, Hawcutt DB, Schaeffeler E, Rane A, de Wildt SN, Schwab M.